Home / Market Reports / Pharma & Healthcare / Global Ranitidine Hydrochloride Capsules Market Growth 2024-2030

Global Ranitidine Hydrochloride Capsules Market Growth 2024-2030

Global Ranitidine Hydrochloride Capsules Market Growth 2024-2030

Product Code:1243532

Published Date: Dec 07,2024

Pages: 109

Region: Global

Category: Pharma & Healthcare

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US 

The global Ranitidine Hydrochloride Capsules market size is predicted to grow from US$ 699 million in 2024 to US$ 1461 million in 2030; it is expected to grow at a CAGR of 13.1% from 2024 to 2030.

Ranitidine   hydrochloride capsules are widely used in the treatment of stomach pain,   heartburn (heartburn), acid reflux and other symptoms caused by excessive   gastric acid. The drug belongs to the H2 receptor antagonist class of drugs,   by inhibiting the gastric parietal cells H2 receptor, reduce gastric acid   secretion, thus achieving therapeutic purposes.

United States market for Ranitidine Hydrochloride Capsules is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Ranitidine Hydrochloride Capsules is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Ranitidine Hydrochloride Capsules is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Ranitidine Hydrochloride Capsules players cover Guangdong Eashu Pharmaceutical Co.,Ltd, Foshan Shouxin Pharmaceutical Co., Ltd, Anhui Aikeer Pharmaceutical Co., Ltd, Hefei Limin Pharmaceutical Co., Ltd, Cspc Ouyi Pharmaceutical Co., Ltd, etc. In terms of revenue, the global two largest companies occupied for a share nearly 
 % in 2023.

LP Information, Inc. (LPI) ' newest research report, the “Ranitidine Hydrochloride Capsules Industry Forecast” looks at past sales and reviews total world Ranitidine Hydrochloride Capsules sales in 2023, providing a comprehensive analysis by region and market sector of projected Ranitidine Hydrochloride Capsules sales for 2024 through 2030. With Ranitidine Hydrochloride Capsules sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ranitidine Hydrochloride Capsules industry.

This Insight Report provides a comprehensive analysis of the global Ranitidine Hydrochloride Capsules landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ranitidine Hydrochloride Capsules portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Ranitidine Hydrochloride Capsules market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ranitidine Hydrochloride Capsules and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ranitidine Hydrochloride Capsules.

This report presents a comprehensive overview, market shares, and growth opportunities of Ranitidine Hydrochloride Capsules market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
    150mg
    300mg

Segmentation by Application:
    Hospital
    Clinic
    Supermarkets
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
    Guangdong Eashu Pharmaceutical Co.,Ltd
    Foshan Shouxin Pharmaceutical Co., Ltd
    Anhui Aikeer Pharmaceutical Co., Ltd
    Hefei Limin Pharmaceutical Co., Ltd
    Cspc Ouyi Pharmaceutical Co., Ltd
    Shijiazhuang Siyao Co., Ltd
    Sanofi
    Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd
    Jilin Aodong Pharmaceutical Group Co., Ltd
    Jiangxi Jimin Ke Xin Pharmaceutical Co., Ltd
    Jiangxi Huiren Pharmaceutical Co., Ltd
    Yunnan Panlong Yunhai Pharmaceutical Co., Ltd
    Guangzhou Baiyunshan Xingqun Pharmaceutical Co., Ltd
    Jiangsu Huanghe Pharmaceutical Co., Ltd
    Shanxi Taiyuan Pharmaceutical Co., Ltd

Key Questions Addressed in this Report
What is the 10-year outlook for the global Ranitidine Hydrochloride Capsules market?
What factors are driving Ranitidine Hydrochloride Capsules market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Ranitidine Hydrochloride Capsules market opportunities vary by end market size?
How does Ranitidine Hydrochloride Capsules break out by Type, by Application?